Prostate Cancer Treatment Clearwater FL
Moffitt Cancer Center in Tampa, Florida, is one of the nation’s top destinations for prostate cancer treatment. At Moffitt, men of all ages come from Clearwater and other nearby areas to access today’s most effective therapies, which we individually tailor to reflect our patients’ unique and wide-ranging needs.
At Moffitt, we provide many advanced forms of prostate cancer treatment, including:
- Traditional and minimally invasive surgical treatments
- Reconstructive surgery and nerve grafting
- Chemotherapy
- Radiation therapy
- Immunotherapy
- Hormone therapy
- Active surveillance
- Clinical trials
- Supportive care services
We understand that each patient’s diagnosis is unique, which is why we create a one-of-a-kind treatment plan for every individual. At Moffitt, we have a collaborative team of specialists who come together as a tumor board to consider complex cases, making customized recommendations based on a number of factors. Our treatment team includes specialists from many different fields, allowing us to create all-inclusive treatment plans that incorporate all available options.
As home to some of the most widely respected experts in the field of prostate tumor treatment, Moffitt is the destination of choice for patients from Clearwater and other nearby areas. And, because we offer a comprehensive scope of services in one location, we make it convenient for patients to access the treatments and supportive care they need and deserve.
At Moffitt, patients do not need referrals. To consult with one of our experienced oncologists regarding your prostate cancer treatment options, call 1-888-663-3488 or submit a new patient registration form online. We welcome patients from Clearwater, FL, and beyond.
Prostate Cancer
- Adrenal Cancer
- Anal Cancer
- Appendiceal (Appendix) Cancer
- Astrocytoma
- Basal Cell Carcinoma
- Bladder Cancer
- Bone Metastasis
- Brain Cancer
- Brain Tumor
- Breast Cancer
- Cervical Cancer
- Cholangiocarcinoma (Bile Duct Cancer)
- Colon Cancer
- Colorectal Cancer
- Cutaneous Lymphoma (CTCL)
- Ductal Carcinoma In Situ
- Endometrial (Uterine) Cancer
- Esophageal Cancer
- Gallbladder Cancer
- Gastrointestinal Carcinoid Tumor
- GIST (Gastrointestinal Stromal Tumor)
- Glioblastoma
- Head and Neck Cancer
- HER2 Positive Breast Cancer
- Hodgkin Lymphoma
- Inflammatory Breast Cancer
- Invasive Ductal Carcinoma
- Kidney (Renal Cell) Cancer
- Leukemia
- Liver (Hepatocellular) Cancer
- Low-Grade Glioma
-
Lung Cancer
- Signs and Symptoms
- Diagnosis
- Treatment
- FAQs
- Lung Cancer Early Detection Center
- Lung Cancer Screening and Surveillance Program
- Lung Nodules
- Lung Surveillance Clinic
- Metastatic Lung Cancer
- Recurrence
- Survival Rate
- Your Lung Cancer Specialists
- Lung and Thoracic Tumor Education (LATTE)
- Thoracic Clinic Updates
- Insurance & Financial Information
- Lymphomas (Hodgkin and Non-Hodgkin)
- Melanoma
- Meningioma
- Merkel Cell Carcinoma
- Mesothelioma
- Metastatic Breast Cancer
- Multiple Myeloma-Plasma Cell Tumor
- Myelodysplastic Syndromes (MDS)
- Neuroendocrine Tumor
- Neurofibromatosis
- Non-Hodgkin Lymphoma
- Oral Cavity (Mouth) Cancer
- Oral Cavity or Throat Cancer
- Osteosarcoma
- Ovarian Cancer
- Pancoast Tumor
- Pancreatic Cancer
- Penile Cancer
- Pituitary Adenoma
- Prostate Cancer
- Rectal Cancer
- Sarcoma
- Skin Cancer (Nonmelanoma)
- Skull Base Tumors
- Small Intestine Cancer
- Spinal Tumor
- Squamous Cell Carcinoma
- Stomach (Gastric) Cancer
- Testicular Cancer
- Throat Cancer
- Thymoma
- Thyroid Cancer
- Tongue Cancer
- Tracheal Cancer
- Triple Negative Breast Cancer
- Vaginal Cancer
- Vulvar Cancer